Ripple kopen? Dit zijn de mogelijkheden

Medtronic Aandeel

97,32USD -0,18USD -0,18%
<
Bedrijf
Kalender
Profiel
>
<
Gerelateerd
Obligaties
>

Medtronic PLC - Profiel

Medtronic Plc is a medical technology company, which develop, manufacture, distribute, and sell device-based medical therapies and services. It also provides services to the hospitals, physicians, clinicians, and patients. It operates through the following segments: Cardiac and Vascular Group; Minimally Invasive Technologies Group; Restorative Therapies Group; and Diabetes Group. The Cardiac and Vascular Group segment consist of three divisions: Cardiac Rhythm & Heart Failure, Coronary & Structural Heart, and Aortic & Peripheral Vascular. The Minimally Invasive Technologies Group segment comprises of three divisions: Surgical Innovations and Respiratory, Gastrointestinal, and Renal. The Restorative Therapies Group contains four divisions: Spine, Brain, Specialty Therapies, and Pain Therapies. The Diabetes Group segment focuses in the development, manufacturing, and marketing of products and services for the management of Type I and Type II diabetes. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Aandeelhouder

Eigenaar in %
Freefloat99,80
The Vanguard Group, Inc.8,19
Wellington Management Co. LLP5,10
BlackRock Fund Advisors5,03
SSgA Funds Management, Inc.4,30
Massachusetts Financial Services Co.4,25
Lazard Asset Management LLC2,08
T. Rowe Price Associates, Inc. (Investment Management)1,62
Geode Capital Management LLC1,31
Northern Trust Investments, Inc.(Investment Management)1,25
Franklin Mutual Advisers LLC1,16
UBS Financial Services, Inc.1,05
Artisan Partners LP1,04
Barrow, Hanley, Mewhinney & Strauss LLC0,99
Norges Bank Investment Management0,92

Adres

20 On Hatch, 2 Dublin
Postbus:
Telefoon: 35314381700
Fax:
Internet: http://www.medtronic.com

Management

Omar S. Ishrak, PhD
Chairman & Chief Executive Officer
Karen L. Parkhill, MBA
Chief Financial Officer & Executive Vice President
Carol A. Surface, PhD
Chief Human Resources Officer & Senior VP
Richard E. Kuntz, MD
Chief Scientific, Clinical & Regulatory Officer
Robert White
EVP & President-Minimally Invasive Therapies
Geoffrey Straub Martha
Executive VP & President-Restorative Therapies
Michael J. Coyle, MBA
Group President-Cardiac & Vascular Group
Ryan Weispfenning
Head-Investor Relations
Randall J. Hogan III, MBA
Independent Director
Robert Charles Pozen
Independent Director
Denise M. O'Leary, MBA
Independent Director
Scott C. Donnelly
Independent Director
Kendall J. Powell, MBA
Independent Director
James T. Lenehan, MBA
Independent Director
Craig Arnold, MBA
Independent Director
Andrea J. Goldsmith, PhD
Independent Director
Michael O. Leavitt
Independent Director
Elizabeth G. Nabel, MD
Independent Director
Richard H. Anderson
Lead Independent Director
Robert J. W. ten Hoedt
President-Europe, Middle East & Africa Region
Bradley E. Lerman
Secretary, Senior Vice President & General Counsel
Fernando Vivanco
Senior Director-Corporate Communications
Scott Lee, MD
Senior Medical Director
Alex Gu
Senior Vice President
Chris Lee
Senior Vice President & President-Asia Pacific
Mark Ploof
Senior Vice President-Global Operations
Michael Weinstein
Senior Vice President-Strategy
Sheri Dodd
VP & GM-Medtronic Care Management Services
Alejandro Galindo
VP & President-Intensive Insulin Management
Laura Mauri
Vice President

Invoer toevoegen